Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sauter, Max
154  Ergebnisse:
Personensuche X
?
1

Extracellular Vesicles as Surrogates for the Regulation of ..:

Rigalli, Juan Pablo ; Gagliardi, Anna ; Diester, Klara...
International Journal of Molecular Sciences.  25 (2024)  7 - p. 4118 , 2024
Link: https://doi.org/10.3390/..
 
?
2

In vitro evaluation of the reductive carbonyl idarubicin me..:

Bajraktari-Sylejmani, Gzona ; Oster, Julia Sophie ; Burhenne, Jürgen...
Archives of Toxicology.  98 (2024)  3 - p. 807-820 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Effect of Tacrolimus Formulation (Prolonged‐Release vs Imme..:

Gümüs, Katja S. ; Teegelbekkers, Anna ; Sauter, Max...
Clinical Pharmacology in Drug Development.  13 (2024)  3 - p. 297-306 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide ..:

Sauter, Max ; Haag, Jonas ; Bay, Cindy...
Pharmaceutics.  15 (2023)  12 - p. 2745 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Persister cell phenotypes contribute to poor patient outcom..:

Zhou, Xu ; An, Jingyu ; Kurilov, Roma...
Nature Cancer.  4 (2023)  9 - p. 1362-1381 , 2023
Link: https://doi.org/10.1038/..
 
?
6

A Nanocarrier Approach for Oral Peptide Delivery: Evaluatio..:

Uhl, Philipp ; Bajraktari‐Sylejmani, Gzona ; Witzigmann, Dominik...
Advanced Therapeutics.  6 (2023)  10 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
7

Correction: Bay et al. Functional Characterization of the S..:

Bay, Cindy ; Bajraktari-Sylejmani, Gzona ; Haefeli, Walter E....
International Journal of Molecular Sciences.  24 (2023)  5 - p. 5029 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Comprehensive in vitro analysis evaluating the variable dru..:

Nilles, Julie ; Weiss, Johanna ; Sauter, Max...
Archives of Toxicology.  97 (2023)  8 - p. 2219-2230 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Influence of a Short Course of Ritonavir Used as Booster in..:

Krohmer, Evelyn ; Rohr, Brit Silja ; Stoll, Felicitas...
Cardiovascular Drugs and Therapy.  , 2023
Link: https://doi.org/10.1007/..
 
?
10

Evaluation of PepT1 (SLC15A1) Substrate Characteristics of ..:

Bajraktari-Sylejmani, Gzona ; von Linde, Teresa ; Burhenne, Jürgen...
Pharmaceutics.  14 (2022)  8 - p. 1610 , 2022
Link: https://doi.org/10.3390/..
 
?
11

Metabolic Effect of Blocking Sodium-Taurocholate Co-Transpo..:

Stoll, Felicitas ; Seidel-Glätzer, Andrea ; Burghaus, Ina...
International Journal of Molecular Sciences.  23 (2022)  24 - p. 15924 , 2022
Link: https://doi.org/10.3390/..
 
?
12

The first-in-class ERK inhibitor ulixertinib shows promisin..:

Sigaud, Romain ; Rösch, Lisa ; Gatzweiler, Charlotte...
Neuro-Oncology.  25 (2022)  3 - p. 566-579 , 2022
Link: https://doi.org/10.1093/..
 
?
13

Functional Characterization of the Solute Carrier LAT-1 (SL..:

Bay, Cindy ; Bajraktari-Sylejmani, Gzona ; Haefeli, Walter...
International Journal of Molecular Sciences.  23 (2022)  7 - p. 3637 , 2022
Link: https://doi.org/10.3390/..
 
?
14

Simultaneous Quantification and Pharmacokinetic Characteriz..:

Kraft, Manuel ; Foerster, Kathrin I. ; Wiedmann, Felix...
Pharmaceutics.  14 (2022)  4 - p. 762 , 2022
Link: https://doi.org/10.3390/..
 
?
15

LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-5..:

Sigaud, Romain ; Rösch, Lisa ; Gatzweiler, Charlotte...
Neuro-Oncology.  24 (2022)  Supplement_1 - p. i93-i93 , 2022
Link: https://doi.org/10.1093/..
 
1-15